Monday, October 14, 2019
News
NEWS HOME
»
PRN INDIA
Pneuma Respiratory and Leads Biolabs, Inc. Announce Partnership
  SocialTwist Tell-a-Friend  
   

BOONE, North Carolina, May 15, 2019 /PRNewswire/ -- Pneuma Respiratory, Inc., developer of a  proprietary breath-activated digital inhaler (BDI), and Leads Biolabs Inc. announce an agreement granting Pneuma an exclusive license to develop Leads Biolabs' panel of immuno-oncology monoclonal antibodies and fusion protein molecules for the pulmonary delivery of Leads' antibodies and molecules.   Using Pneuma's digital inhaler platform, the agreement provides access to the untapped potential of pulmonary delivery of Leads' immuno-oncology therapies in the treatment of oncologic or immune-mediated lung diseases.  

In a recent publication, Pneuma announced the completion of a study demonstrating the feasibility of antibody delivery to the lungs via its digital inhaler platform.  This study, conducted in an animal model, indicates that the Pneuma digital inhaler platform  may provide a method for the pulmonary delivery of monoclonal antibody therapies, enabling the targeted treatment of oncologic or immune-mediated lung diseases.

"This collaboration is an exciting development for the field of immuno-oncology," said Ronald Bukowski, MD, physician emeritus, Cleveland Clinic Foundation.  "Approaches utilizing the regional administration of novel checkpoint inhibitors may provide new treatment opportunities for patients with a variety of malignancies."

"We are pleased to enter into a license agreement for Leads Biolabs monoclonal antibody portfolio," said Pneuma Chief Executive Officer and co-founder Eric Hunter. "We look forward to working with their team to conduct studies that may lead to positive change in the future treatment of non-small cell lung cancer."

Dr. Xiaoqiang Kang, Chairman and CEO of Leads Biolabs, said: "We are very excited to have this license agreement with Pneuma Respiratory. The commitment by a leader in digital pulmonary delivery of drugs is an endorsement of the value of our portfolio. We believe that Pneuma's digital inhaler technology combined with our antibody drugs will create very exciting new opportunities for both companies. We look forward to working with Pneuma to move our candidates into the clinic as quickly as possible."

About Pneuma Respiratory:
Launched in 2015, Pneuma Respiratory is a pharmaceutical company based in Boone, North Carolina. With a global team of researchers, physicians, designers and engineers, Pneuma has created the first fully integrated digital breath-activated inhaler. This inhaled delivery system includes digital micro-fluidics integrated with Bluetooth technology capable of providing feedback on drug delivery to patients, family members, and health care providers. Using Pneuma's digital droplet ejector technology, Pneuma's device has the potential to ultimately deliver a spectrum of novel therapies, including biologics, to the lungs. The first breath-activated digital inhaler (BDI) is currently in use for investigational purposes only and is not yet commercially available. For more information, please visit www.pneumarespiratory.com.

About Leads Biolabs, Inc.:
Leads Biolabs, Inc., a Maryland Corporation, is the fully-owned subsidiary of a US-Sino joint venture company, Nanjing Leads Biolabs Co., Ltd. based in Nanjing, China. Leads Biolabs is an innovation-driven biopharmaceutical company with a rich portfolio of more than 10 novel mono-targeted or bispecific antibody drug projects for cancer immunotherapy and other major diseases to fulfill unmet medical needs. For more information, please visit www.leadsbiolabs.com.

PRIMARY MEDIA CONTACT:
Christy Anglin
canglin@pneumarespiratory.com

Logo - https://mma.prnewswire.com/media/887236/Pneuma_Respiratory_Logo.jpg

More News by PR Newswire India

Bali Zoo Celebrated Tumpek Kandang Ritual for all its Resident Faunas

Nitin Mantri Becomes ICCO President

DMCC Awarded 'Global Free Zone of the Year' for a Record Fifth Consecutive Year

Apex Professional University Signed MoU with Life Science Sector Skill Development Council

Find TVU Networks at Broadcast India 2019

UAE and UNESCO Renew Partnership, Extending Efforts to Restore Historic Churches in Mosul

Over 70,000 Visitors, SR2m Falcon Sales on First Day of Riyadh Exhibition

The First Huion Tablet of Inspiroy Dial Series, Q620M was Unveiled at Hong Kong Electronics Fair

ZEISS showcases next-level eye care digitalization at AAO 2019

On Your Marks: 2019 Xi'an Yango International Marathon Starts 20 October

Autodesk Fusion 360 Tools Enable Social Hardware to Advance Design of Prosthetics

Bionik Gold Knee- A New Lease of Life for Young Arthritis Patients

Joy Forum19 to boost Saudi entertainment sector

UAE and UNESCO Renew Partnership, Extending Efforts to Restore Historic Churches in Mosul

Over 70,000 Visitors, SR2m Falcon Sales on First Day of Riyadh Exhibition

The First Huion Tablet of Inspiroy Dial Series, Q620M was Unveiled at Hong Kong Electronics Fair

ZEISS showcases next-level eye care digitalization at AAO 2019

On Your Marks: 2019 Xi'an Yango International Marathon Starts 20 October

Autodesk Fusion 360 Tools Enable Social Hardware to Advance Design of Prosthetics

Bionik Gold Knee- A New Lease of Life for Young Arthritis Patients

Joy Forum19 to boost Saudi entertainment sector

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
J-K: Postpaid mobile services to be func...
Those in power in Hry will be in Opposit...
Modi crosses 30 million followers on Ins...
Dutch King and Queen arrive in India for...
Isolate nations which aid and abet terro...
Stubble burning continues in Amritsar de...
More...    
 
 Top Stories
Khamenei calls for political soluti... 
Macron, Merkel call for end to Turk... 
Mau : 7 died, 15 injured in house c... 
'Dolittle' Trailer: Robert Downey J... 
UP: Man dies in road mishap in Meer... 
Here's how Megan Fox is celebrating... 
Ancient stories of brotherhood, Man... 
Significant work still to do on Bre...